Kapil K. Sharma

Kapil Sharma is a Utah-based biotech entrepreneur, investor relations leader, and the Founder & CEO of Vira Regen, a regenerative biotechnology company pioneering gene-targeted bioelectronic medicines and electrostimulation technologies for accelerated tissue and bone healing. Based in Salt Lake City, Sharma focuses on developing noninvasive therapies that harness the body’s bioelectric signaling networks to advance treatments for orthopedic injuries, musculoskeletal disorders, osteoarthritis, osteoporosis, and regenerative medicine applications. In addition to leading Vira Regen, Sharma serves in a leadership role at Altitude Lab, Recursion’s premier biotech startup accelerator, where he helps drive startup partnerships, investor engagement, and ecosystem growth across Utah’s rapidly expanding life sciences sector. Through Altitude Lab, he has played a key role in connecting emerging biotech companies with leading investors, strategic partners, and commercialization opportunities while supporting programs focused on advancing early-stage healthcare innovation. Sharma has become an emerging voice within the biotech and medtech community, representing Utah’s innovation ecosystem at major industry conferences, investor summits, and entrepreneurial forums, including LSI USA 2026 and BioUtah’s life sciences initiatives. His work bridges biotechnology, electroceuticals, regenerative medicine, and precision therapeutics to help shape the future of next-generation healing technologies.